Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Interest Coverage Ratio (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Interest Coverage Ratio for 10 consecutive years, with 34.38 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 340.32% to 34.38 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.46 through Dec 2025, up 92.06% year-over-year, with the annual reading at 1.46 for FY2025, 92.06% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 34.38 at Theravance Biopharma, up from 11.27 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 34.38 in Q4 2025, with the low at 45.29 in Q1 2023.
  • Average Interest Coverage Ratio over 5 years is 15.37, with a median of 15.79 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio crashed 973.81% in 2021, then surged 340.32% in 2025.
  • Over 5 years, Interest Coverage Ratio stood at 26.28 in 2021, then fell by 20.59% to 31.69 in 2022, then surged by 68.4% to 10.02 in 2023, then plummeted by 42.85% to 14.31 in 2024, then surged by 340.32% to 34.38 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 34.38, 11.27, and 4.11 for Q4 2025, Q3 2025, and Q2 2025 respectively.